A recent study also found that not a single transgender or gender-diverse child younger than 12, in a group of about 5 million youth studied, received hormones.

Ideally, the research could serve as the starting point for a serious, thoughtful conversation, grounded in reality, so ...

“It echoes past work that has found that gender-affirming medical care, including puberty blockers and hormone treatment, is ...

A new analysis of private insurance claims data finds less than 0.1% of youth accessed puberty blockers or hormones for gender transition.

Among privately insured U.S. adolescents who identified as transgender and gender-diverse (TGD), receipt of puberty blockers ...

Less than 0.1% of teenagers with private insurance in the United States are receiving gender-related medicines, ...

Gender-affirming care was rarely provided to minors from 2018 through 2022, according to new research out of Harvard ...

Less than 0.1% of adolescents in the United States identified as transgender or gender diverse and received puberty blockers ...

The use of gender-affirming medical care for trans teens was rare between 2018 to 2022, according to a new study published in ...

Share articleAs U.S. lawmakers debate issues around health care for transgender youth, it’s been difficult to determine the ...

This year's defense spending bill, signed by President Biden Dec. 24, strips gender-affirming care coverage for military ...

Researchers say among those with private insurance, not one transgender person under 12 was prescribed gender-affirming hormones. “There’s not some massive wave of folks accessing care,” the report's ...